Impact of the COVID-19 pandemic on neoadjuvant endocrine therapy utilization for stage I-III HR+/HER2- breast cancer.

Authors

Kathryn J. Ruddy (ORCID: https://orcid.org/0000-0001-6298-332X)
Bolun Liu (ORCID: https://orcid.org/0000-0001-8508-9371)
Guleid Hussein (ORCID: https://orcid.org/0009-0002-7466-3459)
Sumeet K. Yadav (ORCID: https://orcid.org/0000-0002-2927-1408)
Zhen Wang (ORCID: https://orcid.org/0000-0002-9368-6149)

Institutions

Mayo Clinic Health System (US)
Mayo Clinic in Arizona (US)

Publication Details

Journal: JCO Oncology Practice
Published: 2025-10-01
DOI: https://doi.org/10.1200/op.2025.21.10_suppl.572
Primary Topic: COVID-19 and healthcare impacts
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Impact of the COVID-19 pandemic on neoadjuvant endocrine therapy utilization for stage I-III HR+/HER2- breast cancer.

Kathryn J. Ruddy, Bolun Liu, Guleid Hussein, Sumeet K. Yadav et al.

Oct 1, 2025

JCO Oncology Practice

COVID-19 and healthcare impacts

article

Impact of the COVID-19 pandemic on neoadjuvant endocrine therapy utilization for stage I-III HR+/HER2- breast cancer.

Kathryn J. Ruddy, Bolun Liu, Guleid Hussein, Sumeet K. Yadav, Zhen Wang

October 1, 2025article en

Abstract

No abstract available for this paper.

JCO Oncology PracticeVol. 21(10_suppl)

Mayo Clinic Health System (US), Mayo Clinic in Arizona (US)

Openalex Percentile: Top 62%

COVID-19 and healthcare impacts

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.